Heart A B S T R A C T Given that the lateral plate mesoderm (LPM) gives rise to the cardiovascular system, identifying the cascade of signalling events that subdivides the LPM into distinct regions during development is an important question. Retinoic acid (RA) is known to be necessary for establishing the expression boundaries of important transcription factors that demarcate distinct regions along the anterior posterior axis of the LPM. Here, we demonstrate that fibroblast growth factor (Fgf) signalling is also necessary for regulating the expression domains of the same transcription factors (nkx2.5, foxf1, hand1 and sall3) by restricting the RA responsive LPM domains. When Fgf signalling is inhibited in neurula stage embryos, the more posterior LPM expression domains are lost, while the more anterior domains are extended further posterior. The domain changes are maintained throughout development as Fgf inhibition results in similar domain changes in late stage embryos. We also demonstrate that Fgf signalling is necessary for both the initiation of heart specification, and for maintaining heart specification until overt differentiation occurs. Fgf signalling is also necessary to restrict vascular patterning and create a vascular free domain in the posterior end of the LPM that correlates with the expression of hand1. Finally, we show cross talk between the RA and Fgf signalling pathways in the patterning of the LPM. We suggest that this tissue wide patterning event, active during the neurula stage, is an initial step in regional specification of the LPM, and this process is an essential early event in LPM patterning.
Introduction
The development of organ systems requires signals that specify cell fate and the patterning of cells into distinct regions of the embryo. The coupling of cell fate specification with the coordinated patterning events that define the body plan is fundamental to our understanding of organogenesis. This question is increasingly important, as much of the promise of regenerative medicine depends on differentiating unspecified progenitors into particular cell types and that process generally means cell fate specification without the associated patterning.
Three cell types that are of particular interest in regenerative medicine are cardiomyocytes, endothelial, and smooth muscle cells because these have the potential for improving treatments for cardiovascular disease (Chien et al., 2008; Frontini et al., 2011) and these cell types are derived from the lateral plate mesoderm (LPM). Differentiation of the 0925-4773/$ -see front matter Ó 2011 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2011.06.002 lateral plate mesoderm derivatives can be viewed in two ways. Looking at stem cells to see how these tissues differentiate has pointed out potential precursors that can give rise to one or more of the derivatives. One example of such a precursor is the hemangioblast that can give rise to both hematopoietic and endothelial cells (Xiong, 2008) . In mammals, individual stem cells that can give rise to cardiomyocytes, endothelial cells and smooth muscle cells have also been identified in the early embryo (Ferdous et al., 2009; Martinez-Estrada et al., 2010; Moretti et al., 2006; Yang et al., 2008) . However, when viewed in vivo, these different cell types arise from distinct regions of the embryo implying that spatial cues are important in determining which cell type will form.
In the Xenopus embryo, after gastrulation, the LPM can be divided into several distinct regions along the ventral midline that can be lined up along the rostral/caudal axis. These regions from most rostral to caudal are: the secondary heart field (Brade et al., 2007) , the primary heart field , an anterior, ventral blood island (Smith et al., 2002) , and a posterior, ventral blood island (Ciau-Uitz et al., 2000) . In addition to these distinct regions, the LPM is also essential for patterning the underlying endoderm during the tailbud stage (Horb and Slack, 2001) , suggesting that it must have intrinsic pattern. We have recently described an additional, distinct anterior-posterior pattern in the Xenopus LPM based on the expression of nkx2.5, foxf1, hand1 and sall3 (formerly Xsal1) (Deimling and Drysdale, 2009) .
Retinoic acid signalling is essential for proper patterning within the LPM, including the pattern exhibited by nkx2.5, foxf1, hand1 and sall3 expression (Collop et al., 2006; Deimling and Drysdale, 2009; Keegan et al., 2005; Waxman et al., 2008) . RA signalling clearly alters, but does not eliminate the pattern indicating that additional signalling events are required for this pattern. To better understand how the pattern is generated, we chose to investigate fibroblast growth factor (Fgf) signalling because of the well documented interplay between RA and Fgf signalling in a variety of tissues (Diez del Corral et al., 2003; Moreno and Kintner, 2004; Shiotsugu et al., 2004) . In the early heart field (anterior LPM), both RA (Collop et al., 2006; Hochgreb et al., 2003; Keegan et al., 2005) and Fgf (Alsan and Schultheiss, 2002; Keren-Politansky et al., 2009; Marques et al., 2008; Samuel and Latinkic, 2009 ) have been implicated in proper cardiac specification and patterning. Furthermore, in the posterior pole of the embryo, Fgf signals are also required for proper body axis extension by maintaining the tail bud domain (Griffin et al., 1995; Pownall et al., 1996) . In the mouse, RA acts in opposition to Fgf to pattern both the anterior-posterior axis at the atrial (posterior) end of the heart tube (Sirbu et al., 2008) as well as in the trunk during body axis extension in mouse ). These results led us to hypothesize a dynamic interaction between RA and Fgf signals in conferring coordinate information to cells across the anterior-posterior axis of the early lateral plate mesoderm.
The expression of the enzymes that regulate the levels of retinoic acid and the location of in the embryo support the concept of these two signalling pathways having opposing centres of action that could pattern the LPM. Aldh1a2 (raldh2), the enzyme primarily responsible for RA synthesis during early organogenesis, is expressed at the dorso-anterior shoulder of the LPM (Chen et al., 2001; Lynch et al., 2011) and cyp26 is expressed at the posterior end of the embryo and a region corresponding to the cement gland at the anterior end (de Roos et al., 1999; Hollemann et al., 1998) . Anterior to the aldh1a2 expression domain there is an anterior crescent of fgf8 expression and an additional fgf8 expression domain at the posterior end of the embryo (Christen and Slack, 1997; Shiotsugu et al., 2004) and both correspond to regions of active extracellular signal-regulated protein kinase (ERK) signalling (Christen and Slack, 1999) . Thus, there is potential for two different regions with high RA signalling at one end and high Fgf signalling at the other. First, over the bulk of the LPM there is high RA signalling at the anterior end of the LPM whereas Fgf signalling is high at the posterior end. However, the forming first and second heart fields have high RA signalling at the posterior end and high Fgf signalling on the anterior side.
Using an Fgf receptor inhibitor, that allowed us to bypass the requirements for fgf during early embryogenesis (Amaya et al., 1991; Bottcher and Niehrs, 2005) , we demonstrate that loss of Fgf signalling, after gastrulation, results in a loss of specific anterior-ventral and posterior LPM domains. This alteration of the early patterning has direct consequences for LPM derivatives, including the heart and vascular system. We demonstrate that Fgf signalling is required for both initiation and maintenance of the heart and that myocardial differentiation is able to partially recover if Fgf signalling is restored before heart tube closure is complete. A posterior LPM domain that is normally free of vasculature is also absent when Fgf signalling is lost and the expression domains of two vascular markers, etv2 and aplnr are extended to the posterior limits of the LPM. Therefore, correct patterning of the early Xenopus LPM, and LPM derived cardiovascular cell lineages requires a complex input of Fgf signals in the post gastrula embryo. We propose a model whereby Fgf signals are required to restrict anterior RA responsive domains and to maintain a domain of unspecified mesoderm in the posterior end of the embryo.
Results

Fgf signalling is required for proper patterning of the LPM
We have previously described four distinct domains throughout the LPM along the anterior-posterior axis (Deimling and Drysdale, 2009 ): nkx-2.5 (anterior-ventral LPM; early heart field marker), foxf1 (anterior-dorsal LPM), hand1 (middle LPM) and sall3 (posterior LPM). In this study, we extend the mesoderm domains to include the expression of isl1 (anterior LPM; marker of the secondary heart field in Xenopus (Brade et al., 2007) , and Xbra marking the posterior tail bud domain (Smith et al., 1991) . To test whether Fgf signalling plays a role in the patterning these expression domains, we treated embryos with SU5402, a well established inhibitor of that pathway, at the end of gastrulation (stage 12.5) and examined the expression domains of the described marker genes at time the neural folds close (stage 20).
When Fgf signalling was blocked with SU5402, the expression of foxf1, normally localized to the anterior-dorsal LPM, was expanded toward the ventral pole ( Fig. 1A and B) . In addition, foxf1 is normally restricted to the anterior flank of the embryo at stage 20, but when Fgf signalling is inhibited, foxf1 expression was observed in a narrow band at the posterior end of the LPM near the closed blastopore ( Fig. 1C and D) . Hand1, is normally expressed in an inverted saddle shape in the middle of the LPM. Blocking Fgf signalling resulted in a posterior expansion of the hand1 domain, particularly evident in the dorsal half of the expression domain ( Fig. 1E-H) . As with the other LPM markers, the posterior LPM domain marked by the expression of sall3 was displaced even further posterior when Fgf signalling was inhibited (Fig. 1I-L) . The sall3 expression domain was observed in the region immediately adjacent to the blastopore that normally expresses Xbra. The Xbra expression domain, normally present adjacent to the blastopore, was completely undetectable after treatment with 10 lM SU5402 ( Fig. 1M and N) . Previous studies have demonstrated an absolute requirement for Fgf signalling for Xbra expression (Fletcher and Harland, 2008; Isaacs et al., 1994) and these results extend that requirement to post gastrulation in intact embryos. Therefore, over the entire LPM there is a shift of all domain markers towards the posterior end of the embryo when FGF signalling is lost.
The early LPM pattern is transient as the sall3 expression is rapidly lost after stage 20 (Deimling and Drysdale, 2009) . However, we have previously shown that altered RA signalling, even if altered for a few hours after gastrulation, results in shifts in the expression domains of genes at later stages of LPM development and that these shifts reflect the earlier observed changes. To determine if later LPM patterning was dependent on the early Fgf signalling, SU5402 was applied from stage 12.5 to stage 28-32 and then fixed for analysis. A loss of Fgf signalling during that time resulted in a stunted embryo phenotype (Fig. 2) . Blocking Fgf signalling before or during gastrulation is known to result in shortened embryos due to inhibition of cellular movements during gastrulation and a lack of tail formation (Amaya et al., 1991; Fletcher and Harland, 2008; Isaacs et al., 1994) . As gastrulation was completed when we treated the embryos, we only observed the shortened tail.
At stage 28-30, both hand1 and foxf1 are normally expressed in the anterior two thirds of the LPM, with a defined area free of staining in the posterior LPM in both cases ( Fig. 2A and C) . However, the expression of both markers was detectable in the dorsal half of the LPM and extended all the way to the closed blastopore when Fgf signalling was blocked ( Fig. 2B and D) . Conversely, hoxc10 expression, which is normally restricted to the posterior half of the LPM, was entirely absent in the LPM, and severely restricted in the somitic mesoderm, when Fgf signalling is lost ( Fig. 2E and F) . Lastly, differentiation of the heart, an anterior LPM derivative, was completely lost when the embryo was treated with SU5402 ( Fig. 2G and H ).
2.2.
Fgf signalling is necessary for both initiating and differentiation of the heart field The loss of cardiac markers when Fgf signalling was blocked was expected as nkx2.5 expression has been shown to require Fgf signalling in recent studies of Xenopus heart development (Keren-Politansky et al., 2009; Samuel and Latinkic, 2009 ). To further characterize the requirement for Fgf in cardiogenesis, we examined whether it was required for development of the secondary heart field, characterized by expression of isl1 (Brade et al., 2007) . When Fgf signalling is blocked after gastrulation, the expression of nkx2.5 was essentially below detection and although expression was still detectable, isl1 expression was severely restricted (Fig. 3) .
We next wished to relate these results with our overall LPM effects by determining when Fgf signalling was necessary during heart development. Embryos were treated with SU5402 at successively later stages and assayed for effects on gross heart morphology and differentiation using the expression of nkx2.5 and tnni3 as markers. If Fgf signalling is inhibited immediately after heart specification (stage 12.5), early expression of nkx2.5 is lost ( Fig. 4A and B) and later differentiation is blocked as assessed by tnni3 expression (Figs. 2G, H and 4F) . If Fgf signalling was blocked after stage 20 ( Fig. 4C and G), a time point after nkx2.5 expression is initiated, neither nkx2.5 or tnni3 expression were detectable at stage 32. When embryos were examined shortly after treatment (approximately 3 h), nkx2.5 expression was already lost (data not shown). If Fgf signalling was inhibited after stage 24, expression of both nkx2.5 and tnni3 was detected (Fig. 4) , but the heart did not form a tube.
We next took advantage of the fact that SU5402 can be successfully washed from a Xenopus embryo (Delaune et al., 2005; Fletcher and Harland, 2008) to narrow the window when Fgf signalling is required. If embryos were treated with SU5402 at stage 12.5, and then had Fgf signalling restored at stage 20, expression of both nkx2.5 and tnni3 ( Fig. 4J and N) was detectable by stage 32. However, heart morphology was clearly abnormal with two bilateral patches of either nkx2.5 or tnni3 expression and no indication of tube formation. If the inhibitor was removed at the early tail bud stage (stage 22) both nkx2.5 and tnni3 ( Fig. 4K and O) domains were present in similar bilateral domains but the size of these domains was further reduced. However, if SU5402 was not removed until stage 26, expression of nkx2.5 and tnni3 ( Fig. 4L and P) was lost.
FGF signalling is necessary for patterning the trunk vascular system
Since Fgf signalling was required for patterning the LPM and for differentiation of the heart, we examined its role in patterning the vascular system; another derivative of the LPM. Fgf signalling was blocked after gastrulation (stage 12.5), and embryos were allowed to develop until the tail bud stage (stage 32) when they were fixed and assayed for vascular markers etv2 (Fig. 5A-D) and aplnr ( Fig. 5E-H ). There exists a vascular free region in the posterior trunk of the embryo where the vascular plexus does not appear to form (Salanga et al., 2010) (Fig. 5B and F ). This vascular free zone was lost when Fgf signalling was inhibited, as both etv2 (Fig. 5D ) and aplnr ( Fig. 5H ) expression was extended to the posterior end of the body. In addition, the gap in staining between the rostral lymph sac and the trunk vasculature, seen in the controls and normally occupied at least in part by the heart, is absent. In the SU5402 treated embryos, the trunk vasculature is continuous with staining in the rostral lymph sac ( Fig. 5C and G). It should be noted that vascular precursors that are forming the posterior cardinal veins do extend to the tail in all embryos.
Since SU5402 is known to cross react with the Vegf receptor (Mohammadi et al., 1997) , we tested whether the effects of SU5402 on the early cardiovascular system were due to a loss of Vegf signalling. Embryos were treated with a Vegfr specific inhibitor, KRN633 (Nakamura et al., 2004 ) after gastrulation and assayed for both cardiac and vascular marker expression. Doses of 10 lM, and 25 lM KRN633 were sufficient to block angiogenesis, however there was no detectable effect on either tnni3 expression, or on patterning the posterior limits of the vascular system (Suppl. Fig. 1 ). This suggests that the effects of SU5402 on the heart field, as well as those on the posterior vascular free zone are due to specific interactions with the Fgfrs, and not due to cross reactivity of SU5402 on the Vegf signalling pathway.
We have previously demonstrated that size of the LPM expression domains is dependent on RA signalling (Deimling and Drysdale, 2009 ) and that RA can block differentiation of the heart (Collop et al., 2006; Drysdale et al., 1997) . As the expansion of the middle LPM domains corresponds to the expansion of the vascular system when Fgf signalling is blocked, we predicted that the altered RA signalling treatments that affect the LPM expression domains would also alter the size of the vascular plexus. When RA signalling was blocked with an RA antagonist, expression of either etv2 or aplnr was essentially the same as observed in control embryos (Fig. 5I ,J and O,P). However, increasing RA signalling caused a posterior expansion of the vascular plexus as defined by the expression domains of both etv2 and aplnr (Fig. 5M ,N and S,T). At the anterior end of the embryo, expression in the rostral lymph sac is also significantly decreased with increased RA signalling (Fig. 5 ). This suggests that the extent of vascular patterning in the LPM is limited and that the boundaries are determined, at least in part, by Fgf and RA signalling.
A close correspondence was noted between the size of the vascular free zone and the posterior region of the LPM that does not express hand1 in both normal conditions and under all treatments tested. To demonstrate this correlation in individual embryos, we performed double in situs with probes against hand1 and etv2 using control embryos and embryos that had either Fgf or RA signalling altered. In control embryos and in RA antagonist treated embryos, the vascular free zone at the posterior end of the embryo did not express hand1 (Fig. 6A , B, D and E). When embryos were treated with SU5402, or RA, the vascular free region was eliminated and the hand1 domain extended to the end of the body (Fig. 6C , F, H and J). Despite this tight correlation along the rostral caudal axis, we did observe differences between the expression of hand1 and the pattern of the vascular plexus. When embryos are treated with either RA or SU5402, the correspondence between the hand1 domain and the vasculature was lost when viewed in the dorsal-ventral axis. There is clearly forming Fig. 4 -Fgf signalling is necessary for heart patterning and morphogenesis. Embryos were treated with SU5402 during different developmental windows to determine when Fgf signalling is necessary for heart development and assayed for expression of nkx2.5 (A-D and I-L) or tnni3 (E-H and M-P). Fgf signalling was inhibited at successively later stages (top panel: A-H) and compared to control embryos (A and E). Embryos treated with SU5402 at either stage 12.5 (B and F) or stage 20 (C and G) demonstrate a complete loss of heart marker expression by stage 32, while embryos treated at stage 24 (D and H) show expression of both nkx2.5 and tnni3 but no discernable heart tube. Fgf signalling was also inhibited at stage 12.5 and restored at later stages by removing the inhibitor (bottom panel: I-P) and compared to control embryos (I and M). When Fgf signalling is restored by either stage 20 (J and N) or stage 22 (K and O), both heart markers are expressed however a normal heart tube is not formed. If signalling is not restored until stage 26 (L and P), neither nkx2.5 or tnni3 are detectable. White arrows mark the heart region. The total number of embryos examined for each panel is indicated in the lower left hand corner.
vasculature in ventral regions that do not appear to express hand1 (Fig. 6C , F, H and J).
To further examine potential LPM derivates, we also examined the anterior and ventral blood islands. In the chick embryo, inhibition of Fgf signalling causes ectopic blood formation and inhibits the expression of endothelial cell markers after gastrulation (Nakazawa et al., 2006) . In Xenopus, treatment with SU5402 during gastrulation is known to cause an expansion of ventral blood island markers towards the posterior end of the embryo but little effect was seen when embryos were treated during gastrulation (Walmsley et al., 2008) . In addition, retinoic acid has been shown to inhibit differentiation of haematopoietic precursors but not their formation when the embryos are exposed during mid gastrulation (Bertwistle et al., 1996) . We observed inhibition of haematopoietic differentiation, as assayed by hba1 expression when embryos were either exposed to SU5402 after gastrulation but we did not observe any clear changes in the expression of mpo and spib (markers of primitive myeloid lineage), etv2 (early marker of hematopoietic and endothelial precursors) or scl (marker of the early ventral blood islands), when RA or Fgf signalling was altered after gastrulation (data not shown).
FGF and RA signalling directly interact
Since both RA and Fgf are necessary to pattern separate areas of the LPM, and have been previously shown to form mutually antagonistic gradients in other tissues, we wished to test if the two pathways directly interact in the LPM at the time of our treatments. To determine the effect of the RA signalling pathway on Fgf signalling, embryos were treated with 1 lM RA, RAA or a DMSO control at stage 14 and assayed for both fgf4 and fgf8 expression at the end of neurulation. When RA signalling was antagonized, the anterior trunk domain of fgf8, located just posterior to the cement gland, was decreased in intensity in comparison to staining in the pituitary anlagen when compared to control DMSO treated embryos ( Fig. 7D and E) . However, the posterior domains of both fgf4 and fgf8 remained unaffected (Fig. 7A,B and G,H). Increasing RA signalling by treatment with all-trans RA resulted in an increase in the fgf8 expression domain in ante- rior trunk (Fig. 7E and F) , becoming much thicker and surrounding the entire cement gland rather than residing posterior to it. In the posterior neural tube fgf8 expression, was also extended further anterior along the neural folds ( Fig. 7H and I) in agreement with previous studies (Moreno and Kintner, 2004) . Conversely, the expression domain of fgf4 was decreased in the posterior neural tube to essentially background levels ( Fig. 7B and C) . The increased levels of fgf8 was reflected in increased levels of sprouty2, a direct target of Fgf signalling (Fig. 7J-O) .
To confirm these results we also treated embryos with inhibitors to aldh1a2 (DEAB) and cyp26 (ketoconazole), the endogenous enzymes responsible for RA synthesis and catabolism, respectively. A loss of RA by treatment with DEAB caused a similar reduction in fgf8 staining in the anterior domain similar to RAA treatments (Suppl. Fig. 2 ). We also wished to test the net effect of altering endogenous RA levels on FGF signalling, again using sprouty2 expression as an assay. Sprouty2 is expressed in both anterior and posterior domains overlapping with the fgf8 expression domains (Suppl. Fig. 2N and Q). In either case there are no obvious changes with respect to the size or position of the sprouty2 domain.
To test if Fgf signalling was necessary for proper RA signalling, we treated embryos with 1 lM SU5402 and assayed for expression of both aldh1a2, the enzyme predominantly responsible for in vivo RA synthesis, and cyp26, the enzyme responsible for RA catabolism. Aldh1a2 is normally expressed in the anterior half of the somites and dorsal LPM, as well as the anterior trunk along the anterior border of the LPM. Inhibiting Fgf signalling caused a posterior expansion of the dorsal aldh1a2 domain (Fig. 7P and Q) much further posterior than in control embryos. Cyp26 however, is normally expressed in the posterior neural tube and tail bud domain in a domain reminiscent of the Fgf4 and Fgf8 expression domains, and the Xbra domain (Fig. 7R) . Inhibiting Fgf signalling caused a complete loss of the posterior cyp26 domain in the posterior neural folds and the adjacent tail bud domain (Fig. 7S) , which is consistent with previous studies (Moreno and Kintner, 2004) .
To directly test if up-regulating RA signalling and inhibiting Fgf signalling would accentuate the effects on LPM patterning, we treated stage 12.5 embryos with RA, SU5402 or both and assayed for the expression of LPM markers at stage 20. Treating with RA reduced the expression domain of nkx2.5 when compared to control embryos (Fig. 8) . Treating with SU5402 also significantly reduced nkx2.5 expression to a small patch underlying the cement gland. However, when embryos were treated with both RA and SU5402, nkx2.5 expression was essentially undetectable (Fig. 8A-D) . The isl1 expression domain was also smaller when treated with either RA or SU5402 as compared to controls, but was undetectable in Fig. 6 -The extent of the vascular plexus is related to the size of the hand1 domain. To more directly assess the relationship between the forming vasculature and hand1 expression double in situ hybridizations were done with hand1 being visualized in light blue and etv2, marking the forming vasculature, in purple. The forming vascular plexus (emphasized in the lower panels of each example) along the side of the embryo does not extend to the end of the embryo in control (DMSO, ATP) embryos nor does the hand1 staining. When the extent of the vascular plexus is shifted towards the anterior end by treatment with RAA (A and D) this is reflected in the changes to the hand1 expression domain. When the vascular plexus is shifted towards the end of the embryo by addition of RA (C and F) or SU5402 (H and J) this is again reflected in the changes to the extent of hand1 expression domain along the anterior-posterior axis. Note that the close correspondence appears to be lost in the dorsal ventral axis in the SU5402-treated embryos (H and J).
the heart domain when treated with RA and SU5402 together (Fig. 8E-F) . Conversely, the foxf1 expression domain was expanded when in both the RA and SU5402 treatments. When embryos were treated with both RA and SU5402, foxf1 was expressed over almost the entire LPM (Fig. 8I-L) . The hand1, sall3 and Xbra expression domains were also assayed, but changes are indistinguishable between the RA, SU5402 and RA and SU5402 treatments (data not shown); the sall3 domain is completely undetectable when treated with either RA or RA and SU5402 (data not shown); and the Xbra domain is undetectable when treated with SU5402 or RA and SU5402. Thus any additive effect on these expression domains could not be assessed.
Finally, if the two systems are directly interacting, it would be predicted that the altered pattern caused by reduced Fgf signalling could be rescued by simultaneously blocking RA signalling. To test this, embryos were treated with both SU5402 and the RA antagonist simultaneously from stage 12 to stage 20 and the resulting embryos were assessed for the expression pattern of nkx2.5, isl1, hand1, and Xbra. In regions that would be expected to have high Fgf signalling (presumptive heart and tail region) there did appear to be partial recovery of the specific expression patterns when embryos were treated with both SU5402 and the RA antagonist. In particular, the expression of isl1 was greater when the retinoic acid antagonist was added in addition to SU5402 (Fig. 9E-H) . Expression of Xbra is essentially eliminated by the addition of SU5402 but staining can be detected when the RA antagonist was also added (Fig. 9Q-T) . The loss of nkx2.5 staining in embryos treated with SU5402 was not rescued by blocking RA signalling (Fig. 9A-D) . Also, the expression of hand1 was restricted by the RA antagonist effect but that restriction was not alleviated by the inhibition of Fgf signalling ( Fig. 9I-P) Fig. 7 -The RA and Fgf pathways regulate each other. The levels of RA signalling (A-I) were altered by addition of a synthetic RA antagonist (left column) or all-trans RA (right column) and compared to a DMSO control (centre column). Embryos were assayed for fgf4 (A-C) and fgf8 (D-I) expression. The posterior domain of fgf4 (a) is lost in RA treated embryos (C) when compared to the control (B), but unaffected in embryos treated with RAA. Expression of fgf8 is expanded both anteriorly (E and F) and posteriorly (H and I; compare distance between arrowheads (d) marking the anterior limits of domain, and (e) marking posterior limits of domain) under treatment with RA. Decreasing RA signalling also reduces the anterior domain of fgf8 underlying the heart region (compare ratio of staining intensity between (b) marking the pituitary anlagen to (c)). A similar effect is seen with sprouty2 expression (J-O), as its domain is increased with RA in both the anterior heart region (L; arrowhead f) and it extends further anterior (g) in the dorsal neural tube (O) when compared to controls (K-N). Conversely, embryos were treated with SU5402 and assayed for expression of aldh1a2 (P and Q) or cyp26 (R and S) to determine the effect of a loss of Fgf signalling on the RA signalling pathway. The expression domain of aldh1a2 was expanded posterior (Q) (arrowhead: h -marking posterior limit of expression domain) as compared to control embryos (P). suggesting that direct interactions may have greater importance at the poles of embryo than in the centre of the LPM pattern where RA signalling is predicted to be highest.
Discussion
FGF and LPM patterning
We have previously described an early pattern in the LPM of Xenopus defined by the expression domains of three transcription factors: foxf1, hand1, and sall3 (Fig. 1) . This pattern can be altered by increased retinoic acid signalling that causes the anterior domains (foxf1, hand1) to shift towards the posterior end of the embryo with the posterior domain (sall3) being lost (Deimling and Drysdale, 2009) .
Here, we show that blocking Fgf signalling can alter the same pattern. Blocking Fgf signalling causes an expansion of the anterior markers towards the posterior end of the embryo (Fig. 1) , as does addition of retinoic acid. This opposite effect of RA and Fgf signalling suggests that these two systems are acting in an opposing fashion along the anterior-posterior axis. This is, at least in part, due to one system directly altering components of the other (Fig. 6) . The one result that appears contradictory is that addition of RA increases the levels of fgf8 expression and signalling ( Fig. 7H and I) . The result also appears to contradict the observation that the loss of RA signalling results in an expansion of Fgf signalling in mouse (Ryckebusch et al., 2008; Sirbu et al., 2008; . Previous studies have shown the same expansion at the posterior end of the Xenopus embryo (Moreno and Kintner, 2004) and suggested that the differences may be due to the relatively acute nature (hours) of RA treatments as compared to the chronic loss of RA signalling due to loss of aldh1a2 in knockout mice. We have also shown that treating embryos with RA accentuates the effect of a blocking Fgf signalling in the heart field, as well as the posterior expansion of the anterior-dorsal foxf1 domain (Fig. 8) . This synergistic effect suggests that although the two systems clearly interact, they also have effects that are independent from one another. Similar reciprocal interactions between these two pathways have been described in many embryonic patterning events (Moreno and Kintner, 2004; Shiotsugu et al., 2004; Sirbu et al., 2008) and these results extend that interrelationship to the LPM.
Expression of several Fgfs supports a role for Fgf signalling in regulating the LPM. Fgf8 is expressed at the anterior end of the heart field, supporting a role for fgf8 in heart specification as has previously been shown (Lea et al., 2009 ). SU5402, the inhibitor used in this study, is specific for fgfr1, and fgf8 has been shown to act through fgfr1 (Chung et al., 2008; Scholpp et al., 2004) . Fgfr1 is widely expressed throughout the neurula stage Xenopus embryo suggesting that this signalling system is present in the time and place to have a significant role in patterning of the LPM (Lea et al., 2009) . It is worth noting that fgf4 is also expressed in the posterior neural folds and could contribute to signalling through fgfr1 in the tail bud domain Fig. 8 -Retinoic acid and fgf are opposing signalling molecules in patterning the LPM. Embryos were treated at stage 12 with either RA, SU5402 or both RA and SU5402 and assayed by whole mount in situ hybridization for expression of nkx2.5 (arrowhead a), isl1 (arrowhead b) and foxf1. Treating embryos with RA reduces the expression domain of both nkx2.5 (B) and isl1 (F) compared with controls (A and E). Significantly reduced domains of nkx2.5 and isl1 were also present in SU5402 treated embryos (C), however when embryos are treated with both RA and SU5402 neither marker is detectable (D and H) . The expression domain of foxf1 was expanded in both the RA (J) and SU5402 (K) treatments when compared to controls (I), however when embryos were treated with both RA and SU5402, foxf1 expression was detectible across the entire LPM although expression was still graded. Ant: anterior view with dorsal at top of image. Pos: posterior view with dorsal at top of image. Llv is left lateral view. The total number of embryos examined for each panel is indicated in the lower left hand corner. (Fig. 7) . These expression patterns, coupled with the expression patterns of aldh1a2 and cyp26, the primary regulators of RA availability, suggest a model where these systems contribute to the size regulation of key expression domains within the LPM (Fig. 10) .
Our results indicate that Fgf signalling is at least in part responsible for maintaining the posterior Xbra domain and that requirement continues after gastrulation is complete. This is similar to several studies in Xenopus that show the importance of Fgf signalling in maintaining the tailbud domain (Moreno and Kintner, 2004; Pownall et al., 1996) . In zebrafish, a recent study has pointed out the importance of an autoregulatory loop where brachyury directly activates the expression of cyp26 in order to maintain the tail progenitor zone (Martin and Kimelman, 2010 ). Fgf does not play a role in that autoregulatory loop as blocking Fgf signalling, after gastrulation, had no effect on either cyp26 or brachyury (no tail) expression. Our results suggest that, in Xenopus, Fgf signalling does play a role in the maintenance of this progenitor zone, although a complete understanding of the dynamics of this system will require further characterization of other potential interacting systems such as notch (Moreno and Kintner, 2004) and wnt (Martin and Kimelman, 2010) signalling. We do note that exogenous RA and SU5402 treatments may be inhibiting formation of the tail in different ways as there was a clear difference in the response of the posterior marker sall3 and foxf1. With the addition of RA, the expression of sall3 in the posterior LPM is lost (Deimling and Drysdale, 2009 ) whereas when FGF signalling is blocked, expression of sall3 and foxf1 can be detected in the region that normally expresses Xbra. Fig. 9 -Loss of retinoic acid signalling partially rescues effects of loss of Fgf signalling on the domains of isl1 and Xbra. Decreasing RA signalling in SU5402 treated embryos had little effect on the nkx2.5 domain (D) as it was still present in a highly restricted domain similar to the SU5402 treatment (C). However, a loss of Fgf signalling leads to a loss of isl1 (H) and Xbra (T), while neither domain is changed when RA signalling is lost (F and R). However, when Fgf signalling is decreased in conjunction with reduced RA signalling both isl1 and Xbra expression is detectable in their normal domains (H and T). However, the restriction of the hand1 expression domain under reduced RA condition (J and N) seems to be dominant to the extended domain seen in the SU5402 treated embryos (K and O) as losing both RA and Fgf signalling (L) leads to a restricted domain similar to the RA antagonist alone.
As we observed with the changes caused by altering RA signalling (Deimling and Drysdale, 2009) , the changes in LPM pattern appear to be permanent. The changes in LPM patterning resulting from a loss of Fgf signalling remain detectable in the expression domains of foxf1, hand1, and hoxc10 at later stages (Fig. 2) , consistent with changes observed at earlier stages. Both of the markers present in the anterior-middle LPM, foxf1 and hand1, are expanded towards the posterior end and are detectable throughout the LPM. Our posterior marker, the hoxc10 domain, which is usually present in the posterior half of the LPM, is completely lost when FGF signalling is inhibited. Thus, Fgf signalling is required to define the boundaries between the tail bud domain and the more anterior LPM, and this signalling event is clearly necessary in early development.
3.2.
Significance of the LPM pattern
Although we have documented an anterior-posterior pattern in the LPM, and shown that these domains are shifted by RA (Deimling and Drysdale, 2009) and Fgf (Fig. 2) , it is not immediately apparent as to what these domains represent, with exception of the anterior-ventral nkx2.5 domain. We have now correlated the changes of the LPM boundaries with one derivative of the LPM, the developing vasculature. An endothelial cell free domain can normally be seen in the posterior LPM at the mid to late tailbud stage by the lack of etv2 and aplnr expression ( Fig. 5B and F) . When Fgf signalling is inhibited, that vascular free zone is lost, and both etv2 and aplnr are expressed along the entire axis. Furthermore, there is a second domain which is both etv2 and aplnr free at the anterior end of the LPM between the rostral lymph sac and the body vasculature which corresponds to the heart field ( Fig. 5) . When Fgf signalling is lost, there is no gap between the rostral lymph sac and the trunk vasculature. These results together suggest that Fgf signalling is necessary to restrict vascular patterning both in the anterior-ventral and posterior ends of the LPM. However, the expansion of vascular markers into the anterior end may be a secondary effect as a result of losing the differentiated heart in between the rostral lymph sac and the body vasculature. A posterior expansion of vasculature markers is clearly seen when RA signalling is increased (Fig. 5) .
The tight correlation with the expression of hand1 and the forming vasculature suggests that hand1 may play a role in defining that tissue. In all conditions tested, the extent of hand1 expression corresponded with the extent of the forming vascular plexus (Fig. 6 ) strongly suggesting a role for hand1 in regulating the vascular plexus. In zebrafish, recent studies have suggested that hand2 expression in the LPM is essential for remodelling the extracellular matrix that is required for gut-looping (Yin et al., 2010) and is also necessary for inhibiting fibronectin expression, allowing for normal cardiac fusion (Garavito-Aguilar et al., 2010) . Hand1 has been shown to be important in the development of the yolk sac vasculature in the mouse (Morikawa and Cserjesi, 2004) , at least in part through its regulation of the actin binding protein, Thymosin b4 (Smart et al., 2010) . Thus, hand1 could be regulating the extracellular matrix of the LPM that then controls the extent of the vascular bed or hand1 may be important for regulating the endothelial cell lineage itself. It should be noted that the expression of hand1 does not correspond to all of the vasculature as the posterior cardinal vein and intersomitic vasculature forms in regions that lack hand1 expression. In addition, although vascular progenitor markers appear in a patchy manner, hand1 expression is uniform across the lateral plate suggesting that hand1 is not a marker of early vascular progenitors. At early stages, foxf1 shows a more restricted expression pattern than hand1 but does expand at later stages to closely reflect the hand1 expression domain. Interestingly, foxf1 is also required for formation of the vasculature in mouse (Astorga and Carlsson, 2007) .
In the chick, inhibition of Fgf signalling leads to expanded blood formation while down regulating endothelial cell differentiation (Nakazawa et al., 2006) . This inverse relationship does not appear to exist in Xenopus as we do not see any clear change in the size of the scl domain that marks blood progenitors of the ventral blood island in response to either SU5402, RA or RAA when applied after gastrulation (data not shown). Fgf does play a role in the timing of scl expression and blocking Fgf signalling with SU5402 causes an expansion of the scl domain but this is only observed when SU5402 is applied before gastrulation (Walmsley et al., 2008) , as we found when we added SU5402 after gastrulation to no effect.
Fgf signalling and cardiac development
Fgf8 is expressed in a domain underlying the heart field that suggests it may be an important secreted molecule during Xenopus cardiogenesis and two recent studies have demonstrated a requirement for Fgf signalling during early Xenopus early heart development (Keren-Politansky et al., 2009; Samuel and Latinkic, 2009) . We now extend those results by demonstrating that Fgf signalling is required for the early expression of the secondary heart marker isl1 in addition to its role in regulating nkx2.5 (Fig. 3) . In addition, we demonstrate that Fgf is required throughout early myocardial development to maintain expression of these heart field markers. When embryos are treated with SU5402 at stage 20, a time well after nkx2.5 is first detectable by in situ hybridization, nkx2.5 expression is not maintained and expression of the cardiac differentiation marker, tnni3, is eliminated (Fig. 4) . While this effect can be partially rescued by removing the inhibitor and restoring active signalling, heart morphology is never normal if Fgf signalling is restored at any point after a five hour treatment at stage 20. It is interesting to note that this is the same window of time during which retinoic acid can suppress differentiation of the myocardium (Drysdale et al., 1997) possibly indicating an interaction between these two systems during heart development as is found in cardiac patterning in mouse (Sirbu et al., 2008) .
Coordinated patterning between mesodermal regions is well established. Such reciprocal patterning has been described for adjacent LPM fields including: myocardial and endocardial (Ferdous et al., 2009; Misfeldt et al., 2009), epicardial and myocardial (van Wijk et al., 2009 ) lineages within the heart field, and the heart field and limb bud (Waxman et al., 2008) , and between the heart and vasculature (Schoenebeck et al., 2007) . In addition, LPM derivatives and adjacent non-LPM mesoderm demonstrate reciprocal interactions in both the embryo (Mudumana et al., 2008) and in extraembryonic tissues (Shin et al., 2009) . In each of these examples, cells in close proximity are co-ordinately patterned leading to distinct cell lineages as a result of encountering different extracellular signals. Here, we propose a tissue wide patterning event occurring upstream of these developmental decision points regulated, at least in part, by opposing inputs of RA and Fgf signalling into the LPM. Defects in this process would have significant consequences on the size and position of mesodermally derived structures, such as the heart and vasculature. After this early patterning event, the LPM continues to be subdivided into successively smaller developmental fields leading to proper size and position of organ progenitors. The information presented here may be of particular use in developing methods to differentiate progenitor cells into cell types normally derived from the LPM including myocardial and endothelial cells.
4.
Experimental procedures
Embryo collection
Female Xenopus laevis frogs were injected with 600-700 IU of human chorionic gonadotropin. Eggs were obtained and fertilized in vitro using minced testis in 80% Steinberg's solution. Embryos were dejellied in 2.5% cysteine, pH 8.0, and cultured in 20% Steinberg's solution. Staging of embryos was done according to (Faber and Nieuwkoop, 1994) .
Embryo treatments
The Fgf inhibitor experiments were performed by adding 10 lM SU5402 (Calbiochem) to embryos in conjunction with 0.1 mM ATP, or DMSO with 0.1 mM ATP as a control. The addition of ATP is rarely reported and we found that it greatly enhanced the ability of SU5402 to block Fgf signalling (Suppl. Fig. 3) . With the addition of 0.1 M ATP, we found that treating embryos with a dose of 10 lM SU5402 was sufficient to yield a full loss of Fgf signalling phenotype as judged by a loss of tail bud outgrowth or cardiac differentiation. The ability to block Fgf signalling was also verified by assaying for the expression of sprouty2, a direct target of Fgf signalling (Nutt et al., 2001 ) and 10 lM SU5402 was able to essentially eliminate sprouty2 expression (Suppl. Fig. 4) . To restrict the inhibition of Fgf signalling to specific windows of time, SU5402-treated embryos were moved to a clean dish with 20% Steinberg's without SU5402 or ATP, and the solution was changed every 20 min for 2 h. With this regime Fgf signalling was restored, as assayed by sprouty2 expression, after approximately 2 h (data not shown), consistent with previous reports (Crump et al., 2004; Maroon et al., 2002; Marques et al., 2008; Nechiporuk et al., 2005) .
Retinoic acid signalling was altered by treatment with 1 lM all-trans RA (Sigma), or 1 lM of a pan retinoic acid receptor antagonist (RAA) (Allergan #193109) (Collop et al., 2006; Teng et al., 1997) in 20% Steinberg's solution at stage 14. Stock solutions for both RA and RAA were 1mM dissolved in DMSO, and therefore a control treatment was performed with 0.1% DMSO in 20% Steinberg's solution.
4.3.
In situ hybridization
Whole-mount in situ hybridizations were performed according to (Harland, 1991) with modifications small modifications (Deimling and Drysdale, 2009) . Antisense riboprobes for hand1 (Sparrow et al., 1998) , sall3 (Hollemann et al., 1996) , foxf1 (Koster et al., 1999) , nkx2.5 , hoxc10 (Christen et al., 2003) , tnni3 (cardiac troponin I) , sprouty2 (Genbank Accession# AF369901), isl1 (Brade et al., 2007) , Xbra (Smith et al., 1991) , aplnr (Devic et al., 1996) , etv2 (Salanga et al., 2010) , fgf4 (Isaacs et al., 1992) , fgf8 (Christen and Slack, 1997) , cyp26 (Hollemann et al., 1998) , aldh1a2 (raldh2) (Chen et al., 2001) , hba1 (globin) (Knochel et al., 1987) , scl (Mead et al., 1998) , spib (Costa et al., 2008) and mpo (Smith et al., 2002) were labelled with digoxygenin (Dig)-labelled UTP (Roche Diagnostics) following the protocol by (Harland, 1991) except that incorporating P 32 labelled nucleotides was omitted. BM Purple (Roche Diagnostics) was used as the alkaline phosphatase substrate. After the colour reaction, embryos were fixed for twenty minutes in MEMPFA and endogenous pigment was bleached with 0.5% hydrogen peroxide, 5% formamide, and 0.5% SSC for several hours. Embryos were visualized on a Leica MZ12 dissecting microscope and images were captured using Northern Eclipse software (Empix Imaging; Mississauga, ON, Canada). In each case, more than 20 embryos were assayed over at least three separate replicates. For each conclusion drawn, a minimum of 80% of embryos must have displayed each phenotype. Double whole mount in situ hybridizations were accomplished according to Koga et al. (2007) with the following modifications. The probes were synthesized separately, one probe was labelled with Dig-11-UTP as described above, while a second probe was labelled with fluorescein-12-UTP (Roche Diagnostics). The same in situ hybridization protocol, described above, was used except that the double probe (probe containing the 1.5· concentrated mixture each of the Dig-labelled and fluorescein-labelled probes) was added at the end of the first day in place of a single in situ hybridization probe. Following the first colour reaction the antibody was inactivated in 0.1 M glycine pH 2.0 as previously described (Sive et al., 2000) . The first colour reaction was carried out using BM Purple as the substrate as above and the second colour reaction used 0.5 mg/ml BCIP in alkaline phosphatase buffer as the substrate.
